Sunday, 9 September 2018

13:00 - 14:30

LS-01 | MSD: Biomarkers in immuno-oncology: a new paradigm for the pathology practice

Room A1
Chair: Gilad Vainer, Israel

001 13:00 - 13:10
Welcome and introduction
Gilad Vainer, Israel

002 13:10 - 13:30
PD - L1 testing in NSCLC and beyond: adoption and quality
Julien Adam, France

003 13:30 - 13:50
An oncologist's perspective on immunotherapy and biomarkers in gastric cancer
Sabine Tejpar, Belgium

004 13:50 - 14:10
Implementation of PD-L1 assessment beyond tumour cells
Gilad Vainer, Israel

005 14:10 - 14:30
Q & A / Closing remarks
Gilad Vainer, Israel

LS-02 | Roche: DNA Mismatch Repair (MMR) Testing by Immunohistochemistry and Concordance with Next Generation Sequencing in Colorectal Cancer: An Expert Tumor Board Discussion

Room A3
Chair: Kieran Sheahan, Ireland

001 13:00 - 13:05
Welcome and introduction
Kieran Sheahan, Ireland

002 13:05 - 13:25
Colorectal carcinoma and MMR
Kieran Sheahan, Ireland

003 13:25 - 13:45
Role of sequencing in lynch syndrome diagnosis
Eric Konnick, USA

004 13:45 - 14:00
Tumour board case discussion
Shobhit Baijal, United Kingdom

005 14:00 - 14:20
Tumour board case discussion
Lee Ellis, USA

006 14:20 - 14:30
Q & A
Kieran Sheahan, Ireland

LS-03 | AstraZeneca: Diagnostic Testing for DNA Damage Response: Current Challenges and Future Implications

Barria
Chair: Nicoletta Colombo, Italy

001 13:00 – 13:05
Introduction
Nicoletta Colombo, Italy

002 13:05 – 13:15
BRCA testing in clinical practice – an oncologists perspective
Nicoletta Colombo, Italy

003 13:15 – 13:45
Optimisation of the laboratory workflow for somatic BRCA testing
Ettore Capoluongo, Italy

004 13:45 – 14:15
The Role of gene panels and HRD scar as a clinical tool in women's cancer
Reinhard Büttner, Germany

005 14:15 – 14:25
Q & A
Nicoletta Colombo, Italy

006 14:25 – 14:30
Close
Nicoletta Colombo, Italy

LS-04 | Novartis: BRAF Mutation Testing in the Evolving Melanoma Treatment Landscape

Room E
Chair: Nicola Normanno, Italy

001 13:00 – 13:10
Welcome & introduction
Nicola Normanno, Italy

002 13:10 – 13:25
The evolving landscape of melanoma treatment
Alexander C.J. van Akkooi, The Netherlands

003 13:25 – 13:40
Current testing methods for BRAF mutations in melanoma
Nicola Normanno, Italy

004 13:40 – 13:55
Current and future directions in melanoma biomarkers
Sandi Deans, United Kingdom

005 13:55 – 14:25
Q & A with panel
Nicola Normanno, Italy

006 14:25 – 14:30
Closing remarks
Nicola Normanno, Italy